Preview Citation

Copeland, K. (2015-09-29). The Crime of Being in Charge: Executive Culpability and Collateral Consequences. In FDA in the Twenty-First Century: The Challenges of Regulating Drugs and New Technologies. : Columbia University Press. Retrieved 5 Jul. 2022, from https://columbia.universitypressscholarship.com/view/10.7312/columbia/9780231171182.001.0001/upso-9780231171182-chapter-11.

Copeland, Katrice Bridges. "The Crime of Being in Charge: Executive Culpability and Collateral Consequences." FDA in the Twenty-First Century: The Challenges of Regulating Drugs and New Technologies. : Columbia University Press,  19. Columbia Scholarship Online. Date Accessed 5 Jul. 2022 <https://columbia.universitypressscholarship.com/view/10.7312/columbia/9780231171182.001.0001/upso-9780231171182-chapter-11>.

Copeland, Katrice Bridges. "The Crime of Being in Charge: Executive Culpability and Collateral Consequences." In FDA in the Twenty-First Century: The Challenges of Regulating Drugs and New Technologies, edited by Holly Fernandez Lynch, and I. Glenn Cohen. Columbia University Press, 2015. Columbia Scholarship Online, 2016. doi: 10.7312/columbia/9780231171182.003.0011.

Copeland KB. The Crime of Being in Charge: Executive Culpability and Collateral Consequences. In: FDA in the Twenty-First Century: The Challenges of Regulating Drugs and New Technologies. Columbia University Press; 2015. https://columbia.universitypressscholarship.com/view/10.7312/columbia/9780231171182.001.0001/upso-9780231171182-chapter-11. Accessed July 5, 2022.